Research announcement · University of Eastern Finland · 2023-06-27
A follow-up analysis counted atrial fibrillation diagnoses across the three groups in a five-year vitamin D trial.
In Finland, researchers checked national health records for diagnoses of atrial fibrillation among 2,495 older adults in a vitamin D trial. The participants had been assigned to placebo or one of two vitamin D3 doses.
Over five years, the researchers recorded 76 diagnoses in the placebo group and 59 and 55 in the two vitamin D groups. Only the higher-dose comparison with placebo reached statistical significance on its own.
Most participants started with sufficient vitamin D levels. The authors examined atrial fibrillation in a later analysis of the trial data and described the finding as a signal to test in further research.
